DAVID P. SOUTHWELL - Chief Executive Officer, Director at TScan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
TCRX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by DAVID P. SOUTHWELL since 11 Feb 2025

Holdings reported by DAVID P. SOUTHWELL for TScan Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Voting Common Stock 171,569 $852,441 $4.97 18 May 2022 Direct
Stock Option (Right to Buy) 100,000 02 Feb 2023 Direct Voting Common Stock

Transactions reported by DAVID P. SOUTHWELL for TScan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.